valproic acid has been researched along with levodopa in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (37.04) | 18.7374 |
1990's | 4 (14.81) | 18.2507 |
2000's | 6 (22.22) | 29.6817 |
2010's | 7 (25.93) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Ward, KW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Leijnse-Ybema, HJ; Tan, BK; Zee, MF | 1 |
Marsden, CD; Parkes, JD; Price, PA | 1 |
Godwin-Austen, RB | 1 |
Anavekar, SN; Davis, HT; Tsianco, MC; Wardell, WM | 1 |
Calne, DB; Eng, N; Nutt, J; Plotkin, C; Williams, A; Ziegler, M | 1 |
MacMillan, V | 1 |
Cavagnini, F; Danesi, L; Dubini, A; Invitti, C | 1 |
Calderazzo, L; Cepeda, C; Naquet, R; Stutzmann, JM; Valin, A | 1 |
Dahlström, S; Koulu, M; Lammintausta, R | 1 |
Georgiev, V; Markovska, V | 1 |
Hamada, T; Matsuura, T; Moriwaka, F; Tashiro, K; Yoshida, K | 1 |
Kagaya, A; Motohashi, N; Saito, H; Takebayashi, M; Yamawaki, S | 1 |
Caffarri, G; Capretti, L; Chiodera, P; Cigarini, C; Coiro, V; Gramellini, D; Necchi Ghiri, S; Volpi, R | 1 |
Onofrj, M; Paci, C; Thomas, A | 1 |
Ehrenberg, BL; Eisensehr, I; Noachtar, S; Rogge Solti, S | 1 |
Fernandez, HH; Hicks, CW; Itin, I; Pandya, MM | 1 |
Foote, KD; Hassan, A; Iyer, S; McFarland, NR; Okun, MS; Rodriguez, RL; Sriram, A; Ward, HE | 1 |
Factor, SA; Silver, M | 1 |
Epstein, J; Hayes, MT; Lai, L; Madiedo, CJ | 1 |
1 review(s) available for valproic acid and levodopa
Article | Year |
---|---|
[Myoclonus induced by some benzodiazepines in the Papio papio. Comparison with myoclonus induced by intermittent light stimulation (author's transl)].
Topics: Allylglycine; Animals; Anti-Anxiety Agents; Apomorphine; Diazepam; Levodopa; Lorazepam; Myoclonus; Papio; Photic Stimulation; Serotonin; Valproic Acid | 1982 |
5 trial(s) available for valproic acid and levodopa
Article | Year |
---|---|
Sodium valproate in Huntington's chorea.
Topics: Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Female; Humans; Huntington Disease; Levodopa; Middle Aged; Valerates; Valproic Acid | 1976 |
Sodium valproate in the treatment of levodopa-induced dyskinesia.
Topics: Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valerates; Valproic Acid | 1978 |
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observations.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valproic Acid | 1979 |
Altered neuroendocrine control of GH secretion in normal women of advanced reproductive age.
Topics: Adult; Aging; Dopamine Agonists; Female; GABA Agonists; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Middle Aged; Neurosecretory Systems; Reference Values; Reproduction; Serotonin Receptor Agonists; Sumatriptan; Valproic Acid | 1997 |
Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid.
Topics: Adult; Aged; Anticonvulsants; Antiparkinson Agents; Benserazide; Cross-Over Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Polysomnography; Restless Legs Syndrome; Surveys and Questionnaires; Time Factors; Treatment Outcome; Valproic Acid | 2004 |
21 other study(ies) available for valproic acid and levodopa
Article | Year |
---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
Postmarketing surveillance of new drugs: II. Case studies.
Topics: Azauridine; Bacteriuria; Contraceptives, Oral; Costs and Cost Analysis; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Levodopa; Research Design; United States; United States Food and Drug Administration; Valproic Acid | 1979 |
The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Brain; Dopamine; Female; Hydroxyindoleacetic Acid; Indoles; Levodopa; Rats; Serotonin; Tryptophan; Valproic Acid | 1979 |
Neuroendocrine effects of chronic administration of sodium valproate in epileptic patients.
Topics: Adolescent; Adrenocorticotropic Hormone; Child; Epilepsy; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Prolactin; Thyrotropin; Valproic Acid | 1988 |
Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.
Topics: Adult; Apomorphine; Baclofen; Diazepam; Dopamine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Levodopa; Male; Valproic Acid | 1980 |
Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Levodopa; Male; Picrotoxin; Rats; Stereotyped Behavior; Valproic Acid | 1982 |
Myoclonus and seizures in a patient with parkinsonism: induction by levodopa and its confirmation on SEPs.
Topics: Aged; Electroencephalography; Electromyography; Epilepsies, Myoclonic; Epilepsy, Generalized; Evoked Potentials, Somatosensory; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Seizures; Valproic Acid | 1993 |
Effect of acute treatment with sodium valproate on catecholamine and serotonin synthesis in mouse cerebral cortex.
Topics: Animals; Catecholamines; Cerebral Cortex; Levodopa; Male; Mice; Mice, Inbred ICR; Muscimol; Picrotoxin; Serotonin; Time Factors; Valproic Acid | 1995 |
Reversible parkinsonism induced by prolonged treatment with valproate.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Remission Induction; Seizures; Valproic Acid | 1998 |
Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease.
Topics: Adult; Anticonvulsants; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valproic Acid | 2011 |
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Anticonvulsants; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valproic Acid | 2013 |
Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia.
Topics: Adult; Aged; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Valproic Acid | 2013 |
Successful treatment of dopamine dysregulation syndrome with valproic acid.
Topics: Antimanic Agents; Carbidopa; Compulsive Behavior; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Valproic Acid | 2014 |